Azmi Nabulsi - 15 Jul 2024 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Chief Operating Officer
Signature
/s/ Molly Henderson, Attorney-in-Fact for Azmi Nabulsi
Issuer symbol
PHAT
Transactions as of
15 Jul 2024
Transactions value $
-$127,760
Form type
4
Filing time
17 Jul 2024, 14:52:30 UTC
Previous filing
31 May 2024
Next filing
20 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Sale -$128K -10.9K -4.34% $11.72 240K 15 Jul 2024 Direct F1, F2
holding PHAT Common Stock 3.58K 15 Jul 2024 By 401(k)
holding PHAT Common Stock 786K 15 Jul 2024 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
F2 Includes 1,754 shares acquired in January 2024 and 1 share acquired in July 2024 under the Phathom Pharmaceuticals, Inc. employee stock purchase plan